Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943)

作者: E.H. Herman , R.M. Mhatre , D.P. Chadwick

DOI: 10.1016/0041-008X(74)90031-3

关键词:

摘要: Abstract Daunomycin (50 mg/kg) was lethal to Syrian golden hamsters ( 10 ) within 2–3 days, however, when this same dose given 30 min after 100 mg/kg of 2,6-piperazinedione, 4,4′-propylenedi-, [±]-(ICRF 159) half the animals 5 survived over 21 days. Between 40 and 51% total daunomycin could be recovered unchanged from hamster serum, urine, heart, lung, liver, kidney spleen. The amount these tissues higher (44–69%) in pretreated with ICRF 159. daunomycinone, a metabolite daunomycin, various less at all intervals 159 (0–3% dose) compared 4–9% saline-pretreated hamsters. iv administration rhesus monkey produced hyperglycemia (140%) 15 min, followed by secondary hypoglycemia 1–3 hr. Pretreatment (100 blocked initial increase, but not decrease, blood sugar 3-hr period. increased creatine phosphokinase glutamic-oxaloacetic transaminase serum enzyme activities 13 4.5 times, respectively. Smaller increases were detected glutamic-pyruvic (3.5 times) lactic acid dehydrogenase (2.5 times). attenuated In present experiments, decrease production daunomycinone may an important factor reduction toxicity.

参考文章(12)
E. Schmidt, F.W. Schmidt, H.D. Horn, U. Gerlach, The Importance of the Measurement of Enzyme Activity in Medicine Methods of Enzymatic Analysis. pp. 651- 712 ,(1965) , 10.1016/B978-0-12-395630-9.50129-8
E.H. Herman, J.A. Vick, The acute pharmacological actions of daunomycin in the dog and monkey. Pharmacology. ,vol. 3, pp. 291- 304 ,(1970) , 10.1159/000136083
K. Hellmann, K. A. Newton, D. N. Whitmore, I. W. F. Hanham, J. V. Bond, Preliminary Clinical Assessment of I.C.R.F. 159 in Acute Leukaemia and Lymphosarcoma BMJ. ,vol. 1, pp. 822- 824 ,(1969) , 10.1136/BMJ.1.5647.822
A. M. CREIGHTON, K. HELLMANN, SUSAN WHITECROSS, Antitumour activity in a series of bisdiketopiperazines. Nature. ,vol. 222, pp. 384- 385 ,(1969) , 10.1038/222384A0
N. R. BACHUR, D. H. HUFFMAN, Daunorubicin metabolism: estimation of daunorubicin reductase. British Journal of Pharmacology. ,vol. 43, pp. 828- 833 ,(1971) , 10.1111/J.1476-5381.1971.TB07219.X
A. Huidobro, V. Waravdekar, E. Herman, R. Mhatre, THE POSSIBLE RELATIONSHIP BETWEEN METABOLISM AND CARDIAC TOXICITY OF DAUNOMYCIN AND RELATED COMPOUNDS Journal of Pharmacology and Experimental Therapeutics. ,vol. 178, pp. 216- 222 ,(1971)